Anogenital distance in human male and female newborns: A descriptive, cross-sectional study

被引:163
作者
Salazar-Martinez E. [1 ,2 ]
Romano-Riquer P. [1 ]
Yanez-Marquez E. [1 ]
Longnecker M.P. [3 ]
Hernandez-Avila M. [1 ]
机构
[1] National Institute of Public Health, 62508 Cuernavaca, Morelos
[2] Mexican Institute of Social Security, C.P. 62000, Cuernavaca, Morelos
[3] Natl. Inst. of Environ. Hlth. Sci., National Institutes of Health, Dept. of Health and Human Services, Research Triangle Park, NC 27709
关键词
Birth Weight; Sexual Dimorphism; Congenital Adrenal Hyperplasia; Human Male; Anogenital Distance;
D O I
10.1186/1476-069X-3-8
中图分类号
学科分类号
摘要
Background: In animal studies of the effects of hormonally active agents, measurement of anogenital distance (AGD) is now routine, and serves as a bioassay of fetal androgen action. Although measurement of AGD in humans has been discussed in the literature, to our knowledge it has been measured formally in only two descriptive studies of females. Because AGD has been an easy-to-measure, sensitive outcome in animals studies, we developed and implemented an anthropometric protocol for measurement of AGD in human males as well as females. Methods: We first evaluated the reliability of the AGD measures in 20 subjects. Then measurements were taken on an additional 87 newborns (42 females, 45 males). All subjects were from Morelos, Mexico. Results: The reliability (Pearson r) of the AGD measure was, for females 0.50, and for males, 0.64. The between-subject variation in AGD, however, was much greater than the variation due to measurement error. The AGD measure was about two-fold greater in males (mean, 22 mm) than in females (mean, 11 mm), and there was little overlap in the distributions for males and females. Conclusion: The sexual dimorphism of AGD in humans comprises prima facie evidence that this outcome may respond to in utero exposure to hormonally active agents. © 2004 Salazar-Martinez et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 30 条
[1]  
Hendrickx A.G., Korte R., Leuschner F., Neumann B.W., Prahalada S., Poggel A., Binkerd P.E., Gunzel P., Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus), Teratology, 35, pp. 119-127, (1987)
[2]  
Gray Jr. L.E., Ostby J.S., Kelce W.R., Developmental effects of an environmental antiandrogen: The fungicide vinclozolin alters sex differentiation of the male rat, Toxicol Appl Pharmaco, 129, pp. 46-52, (1994)
[3]  
You L., Casanova M., Archibeque-Engle S., Sar M., Fan L.Q., Heck H.A., Impaired male sexual development in perinatal Sprague-Dawley and Long-Evans hooded rats exposed in utero and lactationally to p,p′-DDE, Toxicol Sci, 45, pp. 62-73, (1998)
[4]  
Mylchreest E., Sar M., Cattley R.C., Foster P.M., Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide, Toxicol Appl Pharmacol, 156, pp. 81-95, (1999)
[5]  
Gray Jr. L.E., Wolf C., Lambright C., Mann P., Price M., Cooper R.L., Ostby J., Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- And diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat, Toxicol Ind Health, 15, pp. 94-118, (1999)
[6]  
Ostby J., Kelce W.R., Lambright C., Wolf C.J., Mann P., Gray Jr. L.E., The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro, Toxicol Ind Health, 15, pp. 80-93, (1999)
[7]  
McIntyre B.S., Barlow N.J., Wallace D.G., Maness S.C., Gaido K.W., Foster P.M., Effects of in utero exposure to linuron on androgen-dependent reproductive development in the male Crl:CD(SD)BR rat, Toxicol Appl Pharmacol, 167, pp. 87-99, (2000)
[8]  
Nagao T., Ohta R., Marumo H., Shindo T., Yoshimura S., Ono H., Effect of butyl benzyl phthalate in Sprague-Dawley rats after gavage administration: A two-generation reproductive study, Reprod Toxicol, 14, pp. 513-532, (2000)
[9]  
Fielden M.R., Halgren R.G., Tashiro C.H., Yeo B.R., Chittim B., Chou K., Zacharewski T.R., Effects of gestational and lactational exposure to Aroclor 1242 on sperm quality and in vitro fertility in early adult and middle-aged mice, Reprod Toxicol, 15, pp. 281-292, (2001)
[10]  
McIntyre B.S., Barlow N.J., Foster P.M., Androgen-mediated development in male rat offspring exposed to flutamide in utero: Permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues, Toxicol Sci, 62, pp. 236-249, (2001)